The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
ACAmancio CarneroCBCarmen Blanco‐AparicioOROliver RennerWLWolfgang LinkJFJuan Fernando Martínez-Leal
Spanish National Cancer Research Centre
Indexed incrossrefpubmed
Abstract
PTEN/PI3K/AKT constitutes an important pathway regulating the signaling of multiple biological processes such as apoptosis, metabolism, cell proliferation and cell growth. PTEN is a dual protein/lipid phosphatase which main substrate is the phosphatidyl-inositol,3,4,5 triphosphate (PIP3), the product of PI3K. Increase in PIP3 recruits AKT to the membrane where it is activated by other kinases also dependent on PIP3. Many components of this pathway have been described as causal forces in cancer. PTEN activity is lost by mutations, deletions or promoter methylation silencing at high frequency in many primary and metastatic human cancers. Germ line mutations of PTEN are found in several familial cancer…
Citation impact
888
total citations
- FWCI
- 19.79
- Percentile
- 100%
- References
- 0
Citations per year
Authors
5Topics & keywords
Keywords
- PTEN
- PI3K/AKT/mTOR pathway
- Protein kinase B
- Cancer research
- Biology
- Gene silencing
- Phosphatase
- Cell biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.